TY - JOUR
T1 - Consensus Quality Measures and Dose Constraints for Lung Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and ASTRO Expert Panel
AU - Puckett, Lindsay L.
AU - Titi, Mohammad
AU - Kujundzic, Ksenija
AU - Dawes, Samantha L.
AU - Gore, Elizabeth M.
AU - Katsoulakis, Evangelia
AU - Park, John H.
AU - Solanki, Abhishek A.
AU - Kapoor, Rishabh
AU - Kelly, Maria
AU - Palta, Jatinder
AU - Chetty, Indrin J.
AU - Jabbour, Salma K.
AU - Liao, Zhongxing
AU - Movsas, Benjamin
AU - Thomas, Charles R.
AU - Timmerman, Robert D.
AU - Werner-Wasik, Maria
AU - Kudner, Randi
AU - Wilson, Emily
AU - Simone, Charles B.
N1 - Publisher Copyright:
© 2023
PY - 2023/9/1
Y1 - 2023/9/1
N2 - Purpose: For patients with lung cancer, it is critical to provide evidence-based radiation therapy to ensure high-quality care. The US Department of Veterans Affairs (VA) National Radiation Oncology Program partnered with the American Society for Radiation Oncology (ASTRO) as part of the VA Radiation Oncology Quality Surveillance to develop lung cancer quality metrics and assess quality of care as a pilot program in 2016. This article presents recently updated consensus quality measures and dose-volume histogram (DVH) constraints. Methods and Materials: A series of measures and performance standards were reviewed and developed by a Blue-Ribbon Panel of lung cancer experts in conjunction with ASTRO in 2022. As part of this initiative, quality, surveillance, and aspirational metrics were developed for (1) initial consultation and workup; (2) simulation, treatment planning, and treatment delivery; and (3) follow-up. The DVH metrics for target and organ-at-risk treatment planning dose constraints were also reviewed and defined. Results: Altogether, a total of 19 lung cancer quality metrics were developed. There were 121 DVH constraints developed for various fractionation regimens, including ultrahypofractionated (1, 3, 4, or 5 fractions), hypofractionated (10 and 15 fractionations), and conventional fractionation (30-35 fractions). Conclusions: The devised measures will be implemented for quality surveillance for veterans both inside and outside of the VA system and will provide a resource for lung cancer–specific quality metrics. The recommended DVH constraints serve as a unique, comprehensive resource for evidence- and expert consensus–based constraints across multiple fractionation schemas.
AB - Purpose: For patients with lung cancer, it is critical to provide evidence-based radiation therapy to ensure high-quality care. The US Department of Veterans Affairs (VA) National Radiation Oncology Program partnered with the American Society for Radiation Oncology (ASTRO) as part of the VA Radiation Oncology Quality Surveillance to develop lung cancer quality metrics and assess quality of care as a pilot program in 2016. This article presents recently updated consensus quality measures and dose-volume histogram (DVH) constraints. Methods and Materials: A series of measures and performance standards were reviewed and developed by a Blue-Ribbon Panel of lung cancer experts in conjunction with ASTRO in 2022. As part of this initiative, quality, surveillance, and aspirational metrics were developed for (1) initial consultation and workup; (2) simulation, treatment planning, and treatment delivery; and (3) follow-up. The DVH metrics for target and organ-at-risk treatment planning dose constraints were also reviewed and defined. Results: Altogether, a total of 19 lung cancer quality metrics were developed. There were 121 DVH constraints developed for various fractionation regimens, including ultrahypofractionated (1, 3, 4, or 5 fractions), hypofractionated (10 and 15 fractionations), and conventional fractionation (30-35 fractions). Conclusions: The devised measures will be implemented for quality surveillance for veterans both inside and outside of the VA system and will provide a resource for lung cancer–specific quality metrics. The recommended DVH constraints serve as a unique, comprehensive resource for evidence- and expert consensus–based constraints across multiple fractionation schemas.
UR - http://www.scopus.com/inward/record.url?scp=85163287912&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85163287912&partnerID=8YFLogxK
U2 - 10.1016/j.prro.2023.04.003
DO - 10.1016/j.prro.2023.04.003
M3 - Article
C2 - 37075838
AN - SCOPUS:85163287912
SN - 1879-8500
VL - 13
SP - 413
EP - 428
JO - Practical radiation oncology
JF - Practical radiation oncology
IS - 5
ER -